Search

Drug therapy in patients with obstructive lung diseases - bronchial asthma (BA) and chronic obstructive pulmonary disease (COPD) - is aimed at preventing and controlling symptoms, reducing the frequency and severity of exacerbations, improve health status and exercise tolerance. One of the main groups of drugs that can reduce and control symptoms in patients with asthma and COPD are glucocorticosteroids (GCS).

Osteoporosis (OP) is a progressive multifactorial systemic skeletal disease resulting from a loss of bone mass and damage of bone structure (microarchitectonics). Chronic obstructive pulmonary disease (COPD) and bronchial asthma (BA) are major contributors to the development of osteoporosis.